Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone for Fatigue in Metastatic Renal Cell Carcinoma
NCT03379012Phase 2Completed
- Start
- Feb 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone undecanoate in fatigue. Started Feb 2016; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT03379012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03379012.